Skip to main navigation Skip to search Skip to main content

Real world efficacy and safety of nintedanib in idiopathic pulmonary fibrosis: A single center, observational study from India.(Original Article)

Press/Media

Period1 Jan 2022

Media coverage

1

Media coverage

  • TitleReal world efficacy and safety of nintedanib in idiopathic pulmonary fibrosis: A single center, observational study from India.(Original Article)
    Media name/outletLung India
    Country/TerritoryIndia
    Date1/01/22
    PersonsSuresh Agarwal
View all 1
View less